{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:28:15Z","timestamp":1790270895452,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81100302"],"award-info":[{"award-number":["81100302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nature Science of Anhui Province","award":["KJ2011A174"],"award-info":[{"award-number":["KJ2011A174"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.intimp.2016.01.013","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T08:15:55Z","timestamp":1453364155000},"page":"76-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL"],"prefix":"10.1016","volume":"32","author":[{"given":"Fengyun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2016.01.013_bb0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1247\/csf.28.105","article-title":"Hepatic stellate cells: unique characteristics in cell biology and phenotype","volume":"28","author":"Sato","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.intimp.2016.01.013_bb0010","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/hep.24276","article-title":"Methods and interest of noninvasive assessment of liver fibrosis are still in debate","volume":"53","author":"Degos","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.01.013_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0020","doi-asserted-by":"crossref","first-page":"G709","DOI":"10.1152\/ajpgi.00451.2010","article-title":"Therapeutic targets in liver fibrosis","volume":"300","author":"Fallowfield","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2009.06.066","article-title":"TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies","volume":"625","author":"Holoch","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.lfs.2009.01.017","article-title":"Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis","volume":"84","author":"Tang","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2016.01.013_bb0035","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.21846","article-title":"Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver","volume":"46","author":"Volkmann","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.01.013_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrm830","article-title":"IAP proteins: blocking the road to death's door","volume":"3","author":"Salvesen","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0045","first-page":"5659","article-title":"Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells","volume":"60","author":"Sasaki","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2016.01.013_bb0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.cdd.4400503","article-title":"Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma","volume":"6","author":"Wagenknecht","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2016.01.013_bb0055","first-page":"7339","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac\/DIABLO release from mitochondria","volume":"61","author":"Zhang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2016.01.013_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1165\/rcmb.2012-0224OC","article-title":"X-linked inhibitor of apoptosis regulates lung fibroblast resistance to Fas-mediated apoptosis","volume":"49","author":"Ajayi","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0065","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1210\/me.2005-0446","article-title":"Role and regulation of nodal\/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia","volume":"20","author":"Wang","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0070","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0399-8320(07)73970-2","article-title":"Liver fibrosis: from mechanisms to treatment","volume":"31","author":"Friedman","year":"2007","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int."},{"key":"10.1016\/j.intimp.2016.01.013_bb0080","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1096\/fasebj.13.15.2105","article-title":"Specificity, diversity, and regulation in TGF-beta superfamily signaling","volume":"13","author":"Piek","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.intimp.2016.01.013_bb0085","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1472-6882-12-156","article-title":"Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats","volume":"12","author":"Yao","year":"2012","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.intimp.2016.01.013_bb0090","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1128\/IAI.72.3.1637-1644.2004","article-title":"Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis","volume":"72","author":"Medeiros","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.intimp.2016.01.013_bb0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10753-014-0031-y","article-title":"NS5ATP9 suppresses activation of human hepatic stellate cells, possibly via inhibition of Smad3\/phosphorylated-Smad3 expression","volume":"38","author":"Zhang","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2016.01.013_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11010-014-2258-1","article-title":"Smad2 protects against TGF-beta1\/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis","volume":"400","author":"Zhang","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2016.01.013_bb0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1053\/jhep.2003.50196","article-title":"Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis","volume":"37","author":"Ueberham","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2016.01.013_bb0110","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI1018","article-title":"Mechanisms of spontaneous resolution of rat liver fibrosis","volume":"102","author":"Iredale","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2016.01.013_bb0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/mp.51.4.204","article-title":"False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate","volume":"51","author":"St\u00e4helin","year":"1998","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.intimp.2016.01.013_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(01)02655-2","article-title":"TGFbeta1 in liver fibrosis: time to change paradigms?","volume":"502","author":"Bauer","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2016.01.013_bb0125","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1074\/jbc.M207728200","article-title":"Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2016.01.013_bb0130","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/030089161009600503","article-title":"The transforming growth factor beta 1\/SMAD signaling pathway involved in human chronic myeloid leukemia","volume":"96","author":"Su","year":"2010","journal-title":"Tumori"},{"key":"10.1016\/j.intimp.2016.01.013_bb0135","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1091\/mbc.E05-02-0149","article-title":"Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization","volume":"16","author":"Uemura","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.intimp.2016.01.013_bb0140","first-page":"27","article-title":"Hepatic fibrosis\u2014role of hepatic stellate cell activation","volume":"4","author":"Safadi","year":"2002","journal-title":"MedGenMed"},{"key":"10.1016\/j.intimp.2016.01.013_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1247\/csf.28.105","article-title":"Hepatic stellate cells: unique characteristics in cell biology and phenotype","volume":"28","author":"Sato","year":"2003","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.intimp.2016.01.013_bb0150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrc2465","article-title":"The TRAIL apoptotic pathway in cancer onset, progression and therapy","volume":"8","author":"Johnstone","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2016.01.013_bb0155","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1517\/14728222.11.10.1299","article-title":"TRAIL in cancer therapy: present and future challenges","volume":"11","author":"Merino","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.intimp.2016.01.013_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2016.01.013_bb0165","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cellsig.2009.05.008","article-title":"Down-regulation of FoxO-dependent c-FLIP expression mediates TRAIL-induced apoptosis in activatedhepatic stellate cells","volume":"21","author":"Park","year":"2009","journal-title":"Cell Signal"},{"key":"10.1016\/j.intimp.2016.01.013_bb0170","first-page":"231","article-title":"X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells","volume":"26","author":"Roa","year":"2003","journal-title":"Clin. Invest. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576916300121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T18:01:18Z","timestamp":1567533678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576916300121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":34,"alternative-id":["S1567576916300121"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.013","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2016.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}